Segment and Related Information (Tables)

12 Months Ended

Dec. 31, 2019

Summary of financial information concerning the Company's reporting segments


	Patient Care						Products & Services
	For the Year Ended December 31,						For the Year Ended December 31,
(in thousands)	2019		2018		2017		2019		2018		2017
Net revenue
Third party	$	905,691	$	857,382	$	851,973	$	192,355	$	191,378	$	188,796
Intersegments		—		—		—		203,496		192,096		178,768
Total net revenue		905,691		857,382		851,973		395,851		383,474		367,564
Material costs
Third party suppliers		250,407		234,409		228,091		107,364		103,608		101,132
Intersegments		24,394		23,792		23,808		179,102		168,304		154,960
Total material costs		274,801		258,201		251,899		286,466		271,912		256,092
Personnel expenses		319,633		312,736		312,695		52,592		51,353		48,395
Other expenses		151,140		140,527		143,598		28,178		24,306		25,855
Depreciation & amortization		18,541		19,113		21,363		10,650		10,197		10,163
Impairment of intangible assets		—		—		—		—		183		54,735
Segment income (loss) from operations	$	141,576	$	126,805	$	122,418	$	17,965	$	25,523	$	(27,676)

Purchase of property, plant and equipment	$	16,102	$	12,781	$	8,163	$	2,368	$	1,890	$	2,153
Purchase of therapeutic program equipment leased to third parties under operating leases	$	—	$	—	$	—	$	6,672	$	9,835	$	6,000

Schedule of reconciliation of reportable segments

A reconciliation of the total of the reportable segment's income (loss) from operations to consolidated income (loss) from operations is as follows:


(in thousands)	2019		2018		2017
Income (loss) from operations
Patient Care	$	141,576	$	126,805	$	122,418
Products & Services		17,965		25,523		(27,676)
Corporate & other		(94,113)		(92,681)		(113,692)
Income (loss) from operations		65,428		59,647		(18,950)
Interest expense, net		34,258		37,566		57,688
Loss on extinguishment of debt		—		16,998		—
Non-service defined benefit plan expense		691		703		736
Income (loss) before income taxes		30,479		4,380		(77,374)
Provision for income taxes		2,954		5,238		27,297
Net income (loss)	$	27,525	$	(858)	$	(104,671)

A reconciliation of the reportable segment net revenue to consolidated net revenue is as follows:


(in thousands)	2019		2018		2017
Net Revenue
Patient Care	$	905,691	$	857,382	$	851,973
Products & Services		395,851		383,474		367,564
Corporate & other		—		—		—
Consolidating adjustments		(203,496)		(192,096)		(178,768)
Consolidated net revenue	$	1,098,046	$	1,048,760	$	1,040,769

A reconciliation of the reportable segment material costs to consolidated material costs is as follows:


(in thousands)	2019		2018		2017
Material costs
Patient Care	$	274,801	$	258,201	$	251,899
Products & Services		286,466		271,912		256,092
Corporate & other		—		—		—
Consolidating adjustments		(203,496)		(192,096)		(178,768)
Consolidated material costs	$	357,771	$	338,017	$	329,223

A reconciliation of the reportable segment purchase of property, plant and equipment to consolidated purchase of property, plant and equipment, including purchases of therapeutic program equipment leased to third parties under operating leases, is as follows:


(in thousands)	2019		2018		2017
Purchase of property, plant and equipment and therapeutic program equipment leased to third parties under operating leases
Patient Care	$	16,102	$	12,781	$	8,163
Products & Services
Property, plant and equipment		2,368		1,890		2,153
Therapeutic program equipment leased to third parties under operating leases		6,672		9,835		6,000
Corporate & other		7,963		4,313		6,039
Total consolidated purchase of property, plant and equipment and therapeutic program equipment leased to third parties under operating leases	$	33,105	$	28,819	$	22,355

A reconciliation of the total of the reportable segment's assets to consolidated assets is as follows:


(in thousands)	2019		2018
Assets
Patient Care	$	552,644	$	415,469
Products & Services		105,673		100,953
Corporate & other		183,936		186,588
Total consolidated assets	$	842,253	$	703,010